Baird Medical Investment Holdings (BDMD) Accumulated Depreciation & Amortization (2023 - 2025)

Baird Medical Investment Holdings has reported Accumulated Depreciation & Amortization over the past 3 years, most recently at $5.9 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 28.9% year-over-year to $5.9 million; the TTM value through Dec 2025 reached $5.9 million, up 28.9%, while the annual FY2025 figure was $5.9 million, 28.9% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $5.9 million at Baird Medical Investment Holdings, up from $4.6 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $5.9 million in Q4 2025 and troughed at $3.6 million in Q4 2023.
  • A 3-year average of $4.7 million and a median of $4.6 million in 2024 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: rose 28.46% in 2024 and later increased 28.9% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $3.6 million in 2023, then increased by 28.46% to $4.6 million in 2024, then increased by 28.9% to $5.9 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for BDMD at $5.9 million in Q4 2025, $4.6 million in Q4 2024, and $3.6 million in Q4 2023.